Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Juerg Nussberger

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Journal of Hypertension|September 26, 2003
Blood pressure regulation in low renin subjectsNoureddine Brakch, Juerg Nussberger
The New England Journal of Medicine|August 23, 2002
Bradykinin-mediated angioedemaJuerg Nussberger, Massimo Cugno, Marco Cicardi
Kidney International|August 30, 2008
Thiazide diuretic monotherapy for hypertension: diuretic's dark side just got darkerFranz H Messerli, Juerg Nussberger, Susan Phung
Hypertension (Dallas, Tex. : 1979)|November 5, 2003
Blood pressure lowering in essential hypertension with an oral renin inhibitor, aliskirenAlice Stanton, Chris Jensen, Juerg Nussberger, et al.
Current Neurovascular Research|March 30, 2011
The renin prosequence enhances constitutive secretion of renin and optimizes renin activityNoureddine Brakch, Flore Allemandou, Irène Keller, et al.
Annales D'Endocrinologie|September 21, 2016
Claire Douillard, Pascal Houillier, Juerg Nussberger and Xavier Girerd in response to the correspondence by Damien Denimal entitled: "Comments on French SFE/SFHTA/AFCE Consensus on Primary aldosteronism, Part 2: Diagnosis First steps". Ann Endocrinol 2016Claire Douillard, Pascal Houillier, Juerg Nussberger, et al.
American Journal of Hypertension|December 4, 2003
Volume expansion enhances plasma endothelin-1Saad Abdel-Sayed, Hans Rudolf Brunner, Juerg Nussberger
Annales D'Endocrinologie|May 15, 2016
SFE/SFHTA/AFCE Consensus on Primary Aldosteronism, part 2: First diagnostic stepsClaire Douillard, Pascal Houillier, Juerg Nussberger, et al.
Journal of Hypertension|March 2, 2006
Renin inhibition with aliskiren: where are we now, and where are we going?Michel Azizi, Randy Webb, Juerg Nussberger, et al.
Hypertension (Dallas, Tex. : 1979)|January 19, 2002
Angiotensin II suppression in humans by the orally active renin inhibitor Aliskiren (SPP100): comparison with enalaprilJuerg Nussberger, Grégoire Wuerzner, Chris Jensen, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Journal of Hypertension|September 26, 2003
Blood pressure regulation in low renin subjectsNoureddine Brakch, Juerg Nussberger
The New England Journal of Medicine|August 23, 2002
Bradykinin-mediated angioedemaJuerg Nussberger, Massimo Cugno, Marco Cicardi
Kidney International|August 30, 2008
Thiazide diuretic monotherapy for hypertension: diuretic's dark side just got darkerFranz H Messerli, Juerg Nussberger, Susan Phung
Hypertension (Dallas, Tex. : 1979)|November 5, 2003
Blood pressure lowering in essential hypertension with an oral renin inhibitor, aliskirenAlice Stanton, Chris Jensen, Juerg Nussberger, et al.
Current Neurovascular Research|March 30, 2011
The renin prosequence enhances constitutive secretion of renin and optimizes renin activityNoureddine Brakch, Flore Allemandou, Irène Keller, et al.
Annales D'Endocrinologie|September 21, 2016
Claire Douillard, Pascal Houillier, Juerg Nussberger and Xavier Girerd in response to the correspondence by Damien Denimal entitled: "Comments on French SFE/SFHTA/AFCE Consensus on Primary aldosteronism, Part 2: Diagnosis First steps". Ann Endocrinol 2016Claire Douillard, Pascal Houillier, Juerg Nussberger, et al.
American Journal of Hypertension|December 4, 2003
Volume expansion enhances plasma endothelin-1Saad Abdel-Sayed, Hans Rudolf Brunner, Juerg Nussberger
Annales D'Endocrinologie|May 15, 2016
SFE/SFHTA/AFCE Consensus on Primary Aldosteronism, part 2: First diagnostic stepsClaire Douillard, Pascal Houillier, Juerg Nussberger, et al.
Journal of Hypertension|March 2, 2006
Renin inhibition with aliskiren: where are we now, and where are we going?Michel Azizi, Randy Webb, Juerg Nussberger, et al.
Hypertension (Dallas, Tex. : 1979)|January 19, 2002
Angiotensin II suppression in humans by the orally active renin inhibitor Aliskiren (SPP100): comparison with enalaprilJuerg Nussberger, Grégoire Wuerzner, Chris Jensen, et al.
Pageof 4